In conversation with... Shun Lu episode artwork

EPISODE · Oct 19, 2025 · 21 MIN

In conversation with... Shun Lu

from Listen to The Lancet · host The Lancet

Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025.

Episode metadata supplied by the publisher feed · Published Oct 19, 2025

NOW PLAYING

In conversation with... Shun Lu

0:00 21:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Listen to The Lancet?

This episode is 21 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on October 19, 2025.

What is this episode about?

Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025.

Can I download this Listen to The Lancet episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!